Preeclampsia-Like Syndrome in a Pregnant Patient With Coronavirus Disease 2019 (COVID-19).
J Obstet Gynaecol Can
; 44(2): 193-195, 2022 02.
Article
in English
| MEDLINE | ID: covidwho-1458741
ABSTRACT
BACKGROUND:
Hypertension, proteinuria, and hepatic dysfunction have been described as manifestations of coronavirus disease 2019 (COVID-19) and are generally accepted as poor prognostic factors. However, these same findings can also occur in pregnant women with preeclampsia, thus creating a diagnostic challenge. CASE We report a case of COVID-19 infection in an otherwise healthy pregnant patient with secondary hypertension, proteinuria, and significant hepatic dysfunction. Maternal placental growth factor (PlGF) testing was used to rule out preeclampsia. The patient received supportive care and improved significantly. She went on to have a spontaneous vaginal term delivery of a healthy male baby.CONCLUSION:
COVID-19 infection in pregnancy may present as preeclampsia-like syndrome. PlGF testing can be used to differentiate preeclampsia from COVID-19 and facilitate appropriate management.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pre-Eclampsia
/
COVID-19
Type of study:
Case report
/
Diagnostic study
/
Prognostic study
Limits:
Female
/
Humans
/
Male
/
Pregnancy
Language:
English
Journal:
J Obstet Gynaecol Can
Journal subject:
Gynecology
/
Obstetrics
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS